U.S., India can work together to fight NCDs

NewsGuard 100/100 Score

"Secretary Clinton's inspiring piece on how the interests of the U.S. and India are aligned on issue after issue compelled me to articulate one more way in which the world's two biggest democracies could pave the way for international co-operation. This is a remarkable opportunity for the U.S. and India to join together in addressing NCDs, chronic non-communicable diseases," Nalini Saligram, founder and CEO of Aroyga World, writes in the Center for Strategic & International Studies' "Smart Global Health" blog. She describes several initiatives underway to curb NCDs, including the mDiabetes text-messaging program being implemented by Aroyga World in India. Both the U.S. and India "have the bold leadership and technology advances needed [to tackle NCDs], and both countries consider the pursuit of healthy living a worthy aspiration and believe fully in the power of innovation," she states (6/15).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.